In this edition of Diabetes Dialogue: Therapeutics, Technology, and Real-World Perspectives our hosts discuss the experiences of their prescribing tirzepatide (Mounjaro) to patients and what types of issues patients have encountered, the prospect of new biosimilar insulins that may be coming to the market, and the misdiagnosis of type 1 diabetes in adult patients.